Sodium tetradecyl sulfate for sclerotherapy treatment of veins: Is compounding pharmacy solution safe?

Dermatologic Surgery

Volumn 30, Issue 12 I, 2004, Pages 1454-1456

  Goldman, Mitchel P ^a  

^a La Jolla Spa MD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLENE GLYCOL MONOETHYL ETHER; FIBROVEIN; TETRADECYL SULFATE SODIUM;

ARTICLE; DRUG CONTAMINATION; DRUG DETERMINATION; DRUG FORMULATION; DRUG SAFETY; PH; PHARMACY; PRIORITY JOURNAL; SCLEROTHERAPY;

EID: 11144227902     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.30502.x     Document Type: Article

References (8)

1. Goldman MP, Bergan JJ. Sclerotherapy Treatment of Varicose and Telangiectatic Leg Veins, 3rd ed. St. Louis: Elsevier, 2002.
2. Reiner L. The activity of anionic surface active compounds in producing vascular obliteration. Proc Soc Exp Biol Med 1946;62:49.
3. Nabatoff RA. Recent trends in the diagnosis and treatment of varicose veins. Surg Gynecol Obstet 1950;90:521.
4. Spencer J, Mathews AW. Stirring debate: as druggists mix customized brews, FDA raises alarm. Wall Street Journal 2004 Feb 27.
5. Muir CK. The toxic effects of some industrial chemicals on rabbit ileum in vitro compared with eye irritancy in vivo. Toxicol Lett 1983;19:309-12.
6. Berte F, Bianchi A, Gregotti C, et al. In vivo and in vitro toxicity of carbitol. Boll Chim Farm 1986;125:401-3.
7. Pereira F, Pereira C, Lacerda MH. Contact dermatitis due to a cream containing chitin and a carbitol. Contact Dermatitis 1998;38:290-1.
8. Dawson TA, Black RJ, Strang WC, et al. Delayed and immediate hypersensitivity to carbitols. Contact Dermatitis 1989;21:52-3.